125 filings
Page 4 of 7
6-K
3t7s0 633yufv
2 Jan 20
Current report (foreign)
5:09pm
6-K
4cwt2xdsrmo2cx9m
2 Jan 20
Current report (foreign)
11:43am
6-K
j0m 2usydugtuggp
20 Dec 19
Current report (foreign)
11:25am
6-K
srvx3a4sbheekugkht
19 Dec 19
Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics
11:42am
6-K
jf82rqj2qo9y 0x5k
17 Dec 19
Current report (foreign)
1:26pm
6-K
hag9e2fsw ew9la
13 Dec 19
Current report (foreign)
7:54am
6-K
2jd678tecis4ie8zdo
6 Dec 19
Current report (foreign)
12:00am
6-K
y15gpuoe14
6 Dec 19
Current report (foreign)
12:00am
6-K
tf9bqg
5 Dec 19
Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
9:28am
6-K
k5jpjmxxqe5yk4ru
19 Nov 19
Current report (foreign)
1:07pm
6-K
evqj c0ne6dlve
13 Nov 19
Current report (foreign)
1:37pm
6-K
biyb7bvkhsi561wl
12 Nov 19
Current report (foreign)
4:42pm
6-K
eyjc1y
12 Nov 19
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:08pm
6-K
w7bm7gw
6 Nov 19
Interim Report for the First Nine Months Ended September 30, 2019
3:37pm
6-K
ss6mv 2nae9ogt1
30 Oct 19
Current report (foreign)
5:11pm
6-K
5ypassx7b2yb lntbr
22 Oct 19
Current report (foreign)
9:45am
6-K
5k05t5mwjj26c1rh
18 Oct 19
CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
9:25am
6-K
8s0rv xl3jlcmf3ztoc
17 Oct 19
Current report (foreign)
1:19pm
6-K
trf2aeh9upb
15 Oct 19
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2019
8:21am
6-K
m2cbieqtds1 8xn2i
2 Oct 19
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:50pm